October 01, 2024
Like whisky (smoky, fruity) or wine (bright, earthy), cannabis has a wide range of aromas.
A new Genome BC-funded project, in partnership with Aurora Cannabis Inc. and researchers from the University of British Columbia (UBC), is sniffing out the most scintillating cannabis smells.
Drs. Joerg Bohlmann from UBC and Jose Celedon of Aurora are working together to characterize the genetic and biochemical basis of aromas in cannabis and establish molecular markers that will be used to develop varieties with high-quality aromas, which is a trait that drives consumer preferences.
Since the legalization of cannabis for recreational use in 2018, Canada has become an international leader in cannabis research and its utility as a high-value crop.
– 30 –
About Genome British Columbia:
Genome BC is a not-for-profit organization that has advanced genomics research and innovation for nearly 25 years, growing a world-class life sciences sector in BC and delivering sustainable benefits for British Columbia, Canada and beyond. Genome BC has attracted over $1 billion in direct co-investment to the province, which has contributed to funding more than 550 genomics research and innovation projects. These initiatives enhance healthcare and address environmental and natural resource challenges, improving the lives of British Columbians. Genome BC also integrates genomics into society by supporting responsible research and innovation and fostering an understanding and appreciation of the life sciences among educators, students and the public. www.genomebc.ca
About Aurora Cannabis:
Aurora is opening the world to cannabis, serving both the medical and consumer markets across Canada, Europe, Australia and South America. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company’s adult- use brand portfolio includes Aurora Drift, San Rafael ’71, Daily Special, Tasty’s, Being and Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd., North America’s leading supplier of propagated agricultural plants. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora’s brands continue to break through as industry leaders in the medical, wellness and adult recreational markets wherever they are launched. Learn more at www.auroramj.com and follow us on X and LinkedIn.
###
Contact: A.G. Klei, Senior Communications Manager, Genome BC
